{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:36:00Z","timestamp":1791275760046,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T00:00:00Z","timestamp":1404345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1038\/leu.2014.210","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T02:41:03Z","timestamp":1404355263000},"page":"304-311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["PKC\u03b6 and PKM\u03b6 are overexpressed in TCF3-rearranged paediatric acute lymphoblastic leukaemia and are associated with increased thiopurine sensitivity"],"prefix":"10.1038","volume":"29","author":[{"given":"S A","family":"Hartsink-Segers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J","family":"Beaudoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M W J","family":"Luijendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Exalto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"Den Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,3]]},"reference":[{"key":"BFleu2014210_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jb\/mvg017","volume":"133","author":"T Hirai","year":"2003","unstructured":"Hirai T, Chida K . Protein Kinase C\u03b6 (PKC\u03b6): activation mechanisms and cellular functions. J Biochem 2003; 133: 1\u20137.","journal-title":"J Biochem"},{"key":"BFleu2014210_CR2","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1128\/MCB.13.8.4770","volume":"13","author":"MT Diaz-Meco","year":"1993","unstructured":"Diaz-Meco MT, Berra E, Municio MM, Sanz L, Lozano J, Dominguez I et al. A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation. Mol Cell Biol 1993; 13: 4770\u20134775.","journal-title":"Mol Cell Biol"},{"key":"BFleu2014210_CR3","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1128\/MCB.13.2.1290","volume":"13","author":"I Dominguez","year":"1993","unstructured":"Dominguez I, Sanz L, Arenzana-Seisdedos F, Diaz-Meco MT, Virelizier JL, Moscat J . Inhibition of protein kinase C zeta subspecies blocks the activation of an NF-kappa B-like activity in Xenopus laevis oocytes. Mol Cell Biol 1993; 13: 1290\u20131295.","journal-title":"Mol Cell Biol"},{"key":"BFleu2014210_CR4","doi-asserted-by":"publisher","first-page":"6157","DOI":"10.1002\/j.1460-2075.1995.tb00306.x","volume":"14","author":"E Berra","year":"1995","unstructured":"Berra E, Diaz-Meco MT, Lozano J, Frutos S, Municio MM, Sanchez P et al. Evidence for a role of MEK and MAPK during signal transduction by protein kinase C zeta. EMBO J 1995; 14: 6157\u20136163.","journal-title":"EMBO J"},{"key":"BFleu2014210_CR5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S1097-2765(01)00361-6","volume":"8","author":"M Leitges","year":"2001","unstructured":"Leitges M, Sanz L, Martin P, Duran A, Braun U, Garc\u00eda JF et al. Targeted disruption of the \u03b6PKC gene results in the impairment of the NF-\u03baB pathway. Mol Cell 2001; 8: 771\u2013780.","journal-title":"Mol Cell"},{"key":"BFleu2014210_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jmb.2005.02.001","volume":"348","author":"H Hernandez-Pigeon","year":"2005","unstructured":"Hernandez-Pigeon H, Quillet-Mary A, Louat T, Schambourg A, Humbert O, Selves J et al. hMutS alpha is protected from ubiquitin-proteasome-dependent degradation by atypical protein kinase C zeta phosphorylation. J Mol Biol 2005; 348: 63\u201374.","journal-title":"J Mol Biol"},{"key":"BFleu2014210_CR7","first-page":"1195","volume":"5","author":"D Ways","year":"1994","unstructured":"Ways D, Posekany K, deVente J, Garris T, Chen J, Hooker J et al. Overexpression of protein kinase C-zeta stimulates leukemic cell differentiation. Cell Growth Differ 1994; 5: 1195\u20131203.","journal-title":"Cell Growth Differ"},{"key":"BFleu2014210_CR8","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1189\/jlb.0708429","volume":"85","author":"H Guo","year":"2009","unstructured":"Guo H, Ma Y, Zhang B, Sun B, Niu R, Ying G et al. Pivotal advance: PKC\u03b6 is required for migration of macrophages. J Leukocyte Biol 2009; 85: 911\u2013918.","journal-title":"J Leukocyte Biol"},{"key":"BFleu2014210_CR9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/CAD.0b013e3283514cc1","volume":"23","author":"H Li","year":"2012","unstructured":"Li H, Wu J, Ying G, Chen L, Lai L, Liu Z et al. J-4: a novel and typical preclinical anticancer drug targeting protein kinase C zeta. Anticancer Drugs 2012; 23: 691\u2013697.","journal-title":"Anticancer Drugs"},{"key":"BFleu2014210_CR10","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1158\/1541-7786.MCR-09-0358","volume":"8","author":"I Nazarenko","year":"2010","unstructured":"Nazarenko I, Jenny M, Keil J, Gieseler C, Weisshaupt K, Sehouli J et al. Atypical protein kinase C \u03b6 exhibits a proapoptotic function in ovarian cancer. Mol Cancer Res 2010; 8: 919\u2013934.","journal-title":"Mol Cancer Res"},{"key":"BFleu2014210_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1128\/MCB.01294-08","volume":"29","author":"AS Galvez","year":"2009","unstructured":"Galvez AS, Duran A, Linares JF, Pathrose P, Castilla EA, Abu-Baker S et al. Protein kinase Czeta represses the interleukin-6 promoter and impairs tumorigenesis in vivo. Mol Cell Biol 2009; 29: 104\u2013115.","journal-title":"Mol Cell Biol"},{"key":"BFleu2014210_CR12","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/carcin\/bgr190","volume":"32","author":"LB Luna-Ulloa","year":"2011","unstructured":"Luna-Ulloa LB, Hern\u00e1ndez-Maqueda JG, Santoyo-Ramos P, Casta\u00f1eda-Patl\u00e1n MC, Robles-Flores M . Protein kinase C \u03b6 is a positive modulator of canonical Wnt signaling pathway in tumoral colon cell lines. Carcinogenesis 2011; 32: 1615\u20131624.","journal-title":"Carcinogenesis"},{"key":"BFleu2014210_CR13","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/nm.2430","volume":"17","author":"B Diouf","year":"2011","unstructured":"Diouf B, Cheng Q, Krynetskaia NF, Yang W, Cheok M, Pei D et al. Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells. Nat Med 2011; 17: 1298\u20131303.","journal-title":"Nat Med"},{"key":"BFleu2014210_CR14","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1016\/S0021-9258(17)41009-X","volume":"252","author":"Y Takai","year":"1977","unstructured":"Takai Y, Kishimoto A, Inoue M, Nishizuka Y . Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. I. Purification and characterization of an active enzyme from bovine cerebellum. J Biol Chem 1977; 252: 7603\u20137609.","journal-title":"J Biol Chem"},{"key":"BFleu2014210_CR15","doi-asserted-by":"publisher","first-page":"8342","DOI":"10.1073\/pnas.90.18.8342","volume":"90","author":"TC Sacktor","year":"1993","unstructured":"Sacktor TC, Osten P, Valsamis H, Jiang X, Naik MU, Sublette E . Persistent activation of the zeta isoform of protein kinase C in the maintenance of long-term potentiation. Proc Natl Acad Sci USA 1993; 90: 8342\u20138346.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014210_CR16","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06045.x","volume":"109","author":"JK Bougie","year":"2009","unstructured":"Bougie JK, Lim T, Farah CA, Manjunath V, Nagakura I, Ferraro GB et al. The atypical protein kinase C in Aplysia can form a protein kinase M by cleavage. J Neurochem 2009; 109: 1129\u20131143.","journal-title":"J Neurochem"},{"key":"BFleu2014210_CR17","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1523\/JNEUROSCI.16-08-02444.1996","volume":"16","author":"P Osten","year":"1996","unstructured":"Osten P, Valsamis L, Harris A, Sacktor TC . Protein synthesis-dependent formation of protein kinase Mzeta in long-term potentiation. J Neurosci 1996; 16: 2444\u20132451.","journal-title":"J Neurosci"},{"key":"BFleu2014210_CR18","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1089\/104454900750058071","volume":"19","author":"BS Marshall","year":"2000","unstructured":"Marshall BS, Price G, Powell CT . Rat protein kinase c zeta gene contains alternative promoters for generation of dual transcripts with 5\u2032-end heterogeneity. DNA Cell Biol 2000; 19: 707\u2013719.","journal-title":"DNA Cell Biol"},{"key":"BFleu2014210_CR19","doi-asserted-by":"publisher","first-page":"40305","DOI":"10.1074\/jbc.M307065200","volume":"278","author":"AI Hernandez","year":"2003","unstructured":"Hernandez AI, Blace N, Crary JF, Serrano PA, Leitges M, Libien JM et al. Protein kinase M zeta synthesis from a brain mRNA encoding an independent protein kinase C zeta catalytic domain. Implications for the molecular mechanism of memory. J Biol Chem 2003; 278: 40305\u201340316.","journal-title":"J Biol Chem"},{"key":"BFleu2014210_CR20","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1523\/JNEUROSCI.5612-06.2007","volume":"27","author":"MT Kelly","year":"2007","unstructured":"Kelly MT, Crary JF, Sacktor TC . Regulation of protein kinase Mzeta synthesis by multiple kinases in long-term potentiation. J Neurosci 2007; 27: 3439\u20133444.","journal-title":"J Neurosci"},{"key":"BFleu2014210_CR21","unstructured":"Sacktor TC The Research Foundation of State University of NY, assignee. Memory Enhancing Protein. US patent 7928070, 19 April 2011."},{"key":"BFleu2014210_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8","volume":"426","author":"MU Naik","year":"2000","unstructured":"Naik MU, Benedikz E, Hernandez I, Libien J, Hrabe J, Valsamis M et al. Distribution of protein kinase Mzeta and the complete protein kinase C isoform family in rat brain. J Comp Neurol 2000; 426: 243\u2013258.","journal-title":"J Comp Neurol"},{"key":"BFleu2014210_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nn829","volume":"5","author":"DSF Ling","year":"2002","unstructured":"Ling DSF, Benardo LS, Serrano PA, Blace N, Kelly MT, Crary JF et al. Protein kinase M[zeta] is necessary and sufficient for LTP maintenance. Nat Neurosci 2002; 5: 295\u2013296.","journal-title":"Nat Neurosci"},{"key":"BFleu2014210_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nn820","volume":"5","author":"EA Drier","year":"2002","unstructured":"Drier EA, Tello MK, Cowan M, Wu P, Blace N, Sacktor TC et al. Memory enhancement and formation by atypical PKM activity in Drosophila melanogaster. Nat Neurosci 2002; 5: 316\u2013324.","journal-title":"Nat Neurosci"},{"key":"BFleu2014210_CR25","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1182\/blood-2012-05-378943","volume":"120","author":"C-H Pui","year":"2012","unstructured":"Pui C-H, Mullighan CG, Evans WE, Relling MV . Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood 2012; 120: 1165\u20131174.","journal-title":"Blood"},{"key":"BFleu2014210_CR26","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.chembiol.2011.08.010","volume":"18","author":"A Lopez-Garcia Laura","year":"2011","unstructured":"Lopez-Garcia Laura A, Schulze J\u00f6rg O, Fr\u00f6hner W, Zhang H, S\u00fc\u00df E, Weber N et al. Allosteric regulation of protein kinase PKC\u03b6 by the N-terminal C1 domain and small compounds to the PIF-pocket. Chem Biol 2011; 18: 1463\u20131473.","journal-title":"Chem Biol"},{"key":"BFleu2014210_CR27","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1200\/JCO.2003.11.031","volume":"21","author":"ML Den Boer","year":"2003","unstructured":"Den Boer ML, Harms DO, Pieters R, Kazemier KM, Gobel U, Korholz D et al. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. J Clin Oncol 2003; 21: 3262\u20133268.","journal-title":"J Clin Oncol"},{"key":"BFleu2014210_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","volume":"10","author":"ML Den Boer","year":"2009","unstructured":"Den Boer ML, van Slegtenhorst M, De Menezes RX, Cheok MH, Buijs-Gladdines JG, Peters ST et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol 2009; 10: 125\u2013134.","journal-title":"Lancet Oncol"},{"key":"BFleu2014210_CR29","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3324\/haematol.2013.084434","volume":"98","author":"SA Hartsink-Segers","year":"2013","unstructured":"Hartsink-Segers SA, Exalto C, Allen M, Williamson D, Clifford SC, Horstmann M et al. Inhibiting Polo-like kinase 1 causes growth reduction and apoptosis in pediatric acute lymphoblastic leukemia cells. Haematologica 2013; 98: 1539\u20131546.","journal-title":"Haematologica"},{"key":"BFleu2014210_CR30","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/leu.2012.256","volume":"27","author":"SA Hartsink-Segers","year":"2013","unstructured":"Hartsink-Segers SA, Zwaan CM, Exalto C, Luijendijk MW, Calvert VS, Petricoin EF et al. Aurora kinases in childhood acute leukemia: the promise of Aurora B as therapeutic target. Leukemia 2013; 27: 560\u2013568.","journal-title":"Leukemia"},{"key":"BFleu2014210_CR31","doi-asserted-by":"publisher","first-page":"6061","DOI":"10.1073\/pnas.90.13.6061","volume":"90","author":"MA Van Dijk","year":"1993","unstructured":"Van Dijk MA, Voorhoeve PM, Murre C . Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lymphoblastoid leukemia. Proc Natl Acad Sci USA 1993; 90: 6061\u20136065.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014210_CR32","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1128\/MCB.14.6.3938","volume":"14","author":"Q Lu","year":"1994","unstructured":"Lu Q, Wright DD, Kamps MP . Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation. Mol Cell Biol 1994; 14: 3938\u20133948.","journal-title":"Mol Cell Biol"},{"key":"BFleu2014210_CR33","doi-asserted-by":"publisher","first-page":"e87602","DOI":"10.1371\/journal.pone.0087602","volume":"9","author":"C Diakos","year":"2014","unstructured":"Diakos C, Xiao Y, Zheng S, Kager L, Dworzak M, Wiemels JL . Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein. PLoS One 2014; 9: e87602.","journal-title":"PLoS One"},{"key":"BFleu2014210_CR34","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.lungcan.2008.05.010","volume":"63","author":"Y Liu","year":"2009","unstructured":"Liu Y, Wang B, Wang J, Wan W, Sun R, Zhao Y et al. Down-regulation of PKC\u03b6 expression inhibits chemotaxis signal transduction in human lung cancer cells. Lung Cancer 2009; 63: 210\u2013218.","journal-title":"Lung Cancer"},{"key":"BFleu2014210_CR35","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1158\/0008-5472.CAN-04-1163","volume":"65","author":"R Sun","year":"2005","unstructured":"Sun R, Gao P, Chen L, Ma D, Wang J, Oppenheim JJ et al. Protein kinase C \u03b6 is required for epidermal growth factor\u2013induced chemotaxis of human breast cancer cells. Cancer Res 2005; 65: 1433\u20131441.","journal-title":"Cancer Res"},{"key":"BFleu2014210_CR36","doi-asserted-by":"publisher","first-page":"e25580","DOI":"10.1371\/journal.pone.0025580","volume":"6","author":"AW Lee","year":"2011","unstructured":"Lee AW . The role of atypical protein kinase C in CSF-1-dependent Erk activation and proliferation in myeloid progenitors and macrophages. PLoS One 2011; 6: e25580.","journal-title":"PLoS One"},{"key":"BFleu2014210_CR37","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1124\/mol.64.2.456","volume":"64","author":"NF Krynetskaia","year":"2003","unstructured":"Krynetskaia NF, Brenner TL, Krynetski EY, Du W, Panetta JC, Ching-Hon P et al. Msh2 deficiency attenuates but does not abolish thiopurine hematopoietic toxicity in Msh2-\/- mice. Mol Pharmacol 2003; 64: 456\u2013465.","journal-title":"Mol Pharmacol"},{"key":"BFleu2014210_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/sj.leu.2403540","volume":"19","author":"BM Frost","year":"2005","unstructured":"Frost BM, Forestier E, Gustafsson G, Nygren P, Hellebostad M, Jonmundsson G et al. Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia. Leukemia 2005; 19: 165\u2013169.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/leu2014210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2014210","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2014210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:04:45Z","timestamp":1684418685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2014210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,3]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["BFleu2014210"],"URL":"https:\/\/doi.org\/10.1038\/leu.2014.210","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,3]]},"assertion":[{"value":"8 February 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}